FIORILLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.760
AS - Asia 2.709
EU - Europa 1.427
SA - Sud America 713
AF - Africa 184
Continente sconosciuto - Info sul continente non disponibili 172
OC - Oceania 9
AN - Antartide 1
Totale 9.975
Nazione #
US - Stati Uniti d'America 4.612
SG - Singapore 1.039
CN - Cina 548
BR - Brasile 529
IT - Italia 499
VN - Vietnam 408
UA - Ucraina 240
DE - Germania 216
BD - Bangladesh 160
HK - Hong Kong 116
FR - Francia 105
IN - India 81
SN - Senegal 73
AR - Argentina 70
CA - Canada 67
SE - Svezia 65
KR - Corea 62
FI - Finlandia 55
TR - Turchia 51
GB - Regno Unito 48
AT - Austria 46
IQ - Iraq 44
MX - Messico 44
ZA - Sudafrica 41
RU - Federazione Russa 33
ID - Indonesia 31
CO - Colombia 21
VE - Venezuela 21
EC - Ecuador 20
PK - Pakistan 20
MA - Marocco 19
NL - Olanda 19
PL - Polonia 19
JP - Giappone 17
MY - Malesia 16
CL - Cile 14
BE - Belgio 13
SA - Arabia Saudita 13
ES - Italia 12
PY - Paraguay 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
EG - Egitto 10
IL - Israele 10
JM - Giamaica 10
PE - Perù 10
AU - Australia 9
KE - Kenya 9
PH - Filippine 9
JO - Giordania 8
TH - Thailandia 8
TN - Tunisia 8
BG - Bulgaria 7
BO - Bolivia 7
DZ - Algeria 7
NP - Nepal 7
CZ - Repubblica Ceca 6
UY - Uruguay 6
CR - Costa Rica 5
IE - Irlanda 5
IR - Iran 5
LB - Libano 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
ET - Etiopia 4
EU - Europa 4
KZ - Kazakistan 4
LT - Lituania 4
AL - Albania 3
AZ - Azerbaigian 3
HN - Honduras 3
HU - Ungheria 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
RO - Romania 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
MK - Macedonia 2
MT - Malta 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AI - Anguilla 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
Totale 9.789
Città #
Singapore 424
Chandler 292
San Jose 236
Ashburn 206
Dallas 206
Council Bluffs 170
New York 166
Beijing 153
Ho Chi Minh City 138
Jacksonville 137
Boardman 134
Hong Kong 114
Hanoi 105
San Mateo 83
Dakar 73
Santa Clara 73
Dearborn 67
Rende 65
Seoul 62
Atlanta 60
Shanghai 60
Los Angeles 54
Lauterbourg 53
Hefei 47
Lawrence 44
Roxbury 44
São Paulo 42
Rome 40
Helsinki 39
Brooklyn 37
Milan 37
Munich 33
Florence 29
Da Nang 28
Vienna 28
Izmir 26
Rio de Janeiro 24
Baghdad 23
Seattle 23
Des Moines 22
Ottawa 22
Frankfurt am Main 20
The Dalles 20
Catanzaro 19
Naples 19
Mexico City 17
Montreal 17
Tokyo 16
Cosenza 15
Haiphong 15
Buffalo 14
Cambridge 14
Chennai 14
Hải Dương 14
Phoenix 14
Toronto 14
Bari 13
Brussels 13
Columbus 13
Inglewood 13
Johannesburg 13
San Francisco 13
Warsaw 13
Dhaka 12
London 12
Mumbai 12
Orem 12
Porto Alegre 12
Turku 12
Wilmington 12
Biên Hòa 11
Boston 11
Guangzhou 11
Ogden 11
Turin 11
Guarulhos 10
Hanover 10
Palermo 10
Tashkent 10
Amsterdam 9
Catania 9
Chicago 9
Kingston 9
Kuala Lumpur 9
New Delhi 9
Stockholm 9
Belo Horizonte 8
Caracas 8
Falkenstein 8
Manchester 8
Amman 7
Ann Arbor 7
Bremen 7
Juiz de Fora 7
Medellín 7
Ninh Bình 7
Omaha 7
Pune 7
Tianjin 7
Bangkok 6
Totale 4.395
Nome #
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics 1.799
Polyunsaturated Fatty Acids and their Role in the Diet of Cancer Patients: An Overview 240
Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway 220
5-(Carbamoylmethylene)-oxazolidin-2-ones as a Promising Class of Heterocycles Inducing Apoptosis Triggered by Increased ROS Levels and Mitochondrial Dysfunction in Breast and Cervical Cancer 212
Bergamot (citrus bergamia risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: An overview 206
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 202
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism 201
A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like Mode 197
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 196
17-Hydroxyprogesterone/Progesterone Receptor B Signalling Disrupts the Metabolic Reprogramming in Breast Cancer Cell Lines 194
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs) 186
Enhanced cellular uptake by "pharmaceutically oriented devices" of new simplified analogues of Linezolid with antimicrobial activity 169
Antibacterial activity of new Beta-lactam compounds 165
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 162
Sericin/Poly(ethylcyanoacrylate) Nanospheres by Interfacial Polymerization for Enhanced Bioefficacy of Fenofibrate: In Vitro and In Vivo Studies 158
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 156
ERRα PATHWAY AND ENDOCRINE RESISTANCE ON BREAST CANCER: CHOLESTEROL AND MEVALONATE INVOLVEMENT 155
Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy 155
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 154
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast 154
Characterization of new mitochondrial carriers in Drosophila melanogaster”. 151
The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment 147
Exploiting Glycyrrhiza glabra L. (Licorice) Flavanones: Licoflavanone’s Impact on Breast Cancer Cell Bioenergetics 142
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 136
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 133
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells 132
Thioalbamide, a thioamidated peptide from Amycolatopsis alba, affects tumor growth and stemness by inducing metabolic dysfunction and oxidative stress 129
Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production 129
Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): "In vivo" studies 126
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells 123
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells 122
New insights into cholesterol-mediated ERRα activation in breast cancer progression and pro-tumoral microenvironment orchestration 121
New insights about the structural rearrangements required for substrate translocation in the bovine mitochondrial oxoglutarate carrier 121
Doxycycline, Azithromycin and vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) 119
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 115
GENOMICS-BASED DISCOVERY AND ANTICANCER ACTIVITY ASSESSMENT OF NEW THIOVIRIDAMIDE-LIKE MOLECULES PRODUCED BY ACTINOBACTERIA 114
"Energetic" cancer stem cells (e-CSCs): A new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy 113
Thioalbamide inhibits FoF1-ATPase in breast cancer cells and reduces tumor proliferation and invasiveness in breast cancer in vivo models 112
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 110
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase 110
Two functionally different mitochondrial phosphate carriers support Drosophila melanogaster OXPHOS throughout distinct developmental stages 109
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via "differentiation-based nano-therapy" 109
Mass Spectrometry-Based Proteomic Approach in Oenococcus oeni Enological Starter 104
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 104
Oxazolidinones-mediated mitochondrial dysfunction promotes cell death and cancer stemness inhibition in breast and cervical cancer 99
Impact of COVID-19 Lockdown on Metabolic/Inflammatory Profile in Adolescents: Cellular Studies and Predictive Biomarkers 99
Multifunctional Microspheres Based on D-Mannose and Resveratrol for Ciprofloxacin Release 94
Novel CD44-Targeted Albumin Nanoparticles: An Innovative Approach to Improve Breast Cancer Treatment 94
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 93
Merging fusogenic DOPE and a tumour targeted self-assembling biopolymer: Smart hybrid liposomes for drug vectorization in cancer therapy 89
Sntesi ed attività antimicrobica di nuovi derivati b-lattamici 84
New Oxazolidin-2-ones of antimicrobial activity 81
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer 78
High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy 78
New Oxazolidin-2-ones with antimicrobial activity 74
New β-Lactam derivatives: synthesis and antimicrobial properties. 74
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy 71
New simplified analogues of linezolid with antimicrobial activity. 70
Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling 66
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 62
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 61
Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy 60
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs) 56
Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia 53
Biomarkers of multimorbidity: A systematic review 37
Adipocyte‑derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross‑talk between cancer cells and the tumor microenvironment 36
Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor–Positive Breast Cancer Cells 31
Harnessing the novel safeguarding role of Selenoprotein T in age-related myocardial left and right decline through the ferroptosis-mitochondrial axis 25
Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs 24
Relapse Despite MRD Negativity in Multiple Myeloma: Toward Integrated Risk Prediction 19
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration 18
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells 12
Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-Making 7
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational Opportunities 7
From necroptosis to neuroinflammation: Unraveling mechanisms and therapeutic targets in age-related cognitive decline 6
ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer 5
Totale 9.975
Categoria #
all - tutte 45.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.016


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022396 0 0 2 20 45 9 2 98 21 3 68 128
2022/2023774 100 80 21 79 103 55 13 111 95 27 59 31
2023/2024595 67 20 35 16 31 183 21 29 62 33 16 82
2024/20251.247 86 149 19 74 79 74 90 73 192 88 112 211
2025/20264.025 418 237 346 287 582 244 462 224 306 304 331 284
2026/20272.179 1.991 159 29 0 0 0 0 0 0 0 0 0
Totale 9.975